Tag Archives: William Tanner

Why Did Cantor Fitzgerald Downgrade Aquinox Pharmaceuticals’ Stock?

Aquinox Pharmaceuticals (NASDAQ: AQXP) received a Hold rating and a $2 price target from Cantor Fitzgerald analyst William Tanner today. The company’s shares opened today at $2.68, close to its 52-week low of $2.25. Tanner wrote: “: We are downgrading

Cantor Fitzgerald Reaffirms Their Buy Rating on Prothena Corp

Cantor Fitzgerald analyst William Tanner reiterated a Buy rating on Prothena Corp (NASDAQ: PRTA) yesterday and set a price target of $18. The company’s shares closed yesterday at $14.70, close to its 52-week low of $10.43. Tanner observed: “We are

Analysts Offer Insights on Healthcare Companies: TherapeuticsMD (NYSE MKT: TXMD) and Ampliphi Biosciences (AMEX: APHB)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TherapeuticsMD (NYSE MKT: TXMD) and Ampliphi Biosciences (AMEX: APHB) with bullish sentiments. TherapeuticsMD (NYSE MKT: TXMD) In a report released yesterday, William

Cantor Fitzgerald Reiterates a Buy Rating on TherapeuticsMD

Cantor Fitzgerald analyst William Tanner reiterated a Buy rating on TherapeuticsMD (NYSE MKT: TXMD) yesterday and set a price target of $26. The company’s shares closed yesterday at $5.82. Tanner noted: “: We are reiterating our Overweight rating and $26

Cantor Fitzgerald Reiterates a Buy Rating on Corium

In a report released today, William Tanner from Cantor Fitzgerald reiterated a Buy rating on Corium (NASDAQ: CORI), with a price target of $14. The company’s shares opened today at $9.12. Tanner observed: “Our CORI , 2019E — — —

Analysts Are Bullish on These Healthcare Stocks: CBAY, WMGI

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CymaBay Therapeutics (NASDAQ: CBAY) and Wright Medical Group (NASDAQ: WMGI) with bullish sentiments. CymaBay Therapeutics (NASDAQ: CBAY) Cantor Fitzgerald analyst William Tanner